For healthcare professionals

Patient referrals, and support for your team

Two ways to work together: patient referrals for pre- and post-test genetic counselling, with a written summary for you if the patient consents, and services for clinicians, units and hospitals. Test ordering and clinical management remain the responsibility of the treating team, with the patient’s consent and involvement in decisions.

Training and clinical experience

  • Master’s in Genética Asistencial (Healthcare Genetics), specialising in genetic counselling, Universitat Autònoma de Barcelona (EBMG-accredited programme)
  • Clinical training: Catalan Institute of Oncology (ICO), in hereditary cancer services and multidisciplinary oncology teams; Germans Trias i Pujol University Hospital, in genetics (Spain)
  • PhD in molecular biology (National and Kapodistrian University of Athens), over 15 years of research, Marie Skłodowska-Curie postdoctoral fellowship
  • External collaborator of the Breast Center, Metropolitan Hospital, Athens

Approach

I work to the internationally accepted definition of genetic counselling (Resta et al., 2006): risk assessment and patient education, together with counselling that supports informed decisions and adaptation to risk. I follow a shared decision-making model: patients understand their options, express their priorities and take a meaningful part in decisions with the treating team.

Reference: Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, Williams JL. A new definition of genetic counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns. 2006;15(2):77–83. doi:10.1007/s10897-005-9014-3

When to refer a patient

  • Several relatives on the same side with the same or related cancers
  • A known pathogenic or likely pathogenic variant in the family
  • Multiple primary cancers in one person
  • Breast cancer at a young age, triple-negative, bilateral or male breast cancer
  • Epithelial ovarian, fallopian tube or primary peritoneal cancer, at any age
  • Pancreatic cancer; metastatic or high-risk prostate cancer
  • Colorectal or endometrial cancer with mismatch-repair deficiency (dMMR/MSI-H), or diagnosed at a young age
  • Germline or tumour sequencing results that need interpretation, including variants of uncertain significance (tumour-only findings do not necessarily indicate a germline predisposition)

Criteria differ between guidelines and settings. When in doubt, get in touch.

What your patient receives

Pre-test counselling: personal and family history, a detailed pedigree, testing options and an informed-consent discussion.

Post-test counselling: interpretation of the result, implications for care, family communication, cascade testing and psychosocial support.

What you receive

With the patient’s consent, a structured written summary covering family history and pedigree, hereditary risk assessment, testing rationale or result interpretation, and points for clinical follow-up.

Working together allows the treating clinician to offer specialist genetic counselling without having to manage the detailed assessment of family history, interpretation of complex genetic findings or counselling of relatives personally. Patients receive tailored support and return to their treating team with a clearer understanding of the findings and their options, while maintaining continuity of care.

How to refer

  1. Get in touch

    Use the form for healthcare professionals on the contact page. Please do not include information that identifies the patient.

  2. Secure handover

    I reply to agree a secure way to share referral details and any reports.

  3. Counselling and summary

    I see the patient online or in person. After the consultation, I prepare a written summary. With the patient’s consent, it can be shared securely with the referring clinician.

Services for clinicians, units and hospitals

For teams that want to strengthen the genetic care of their patients without building their own genetic counselling service.

Case consultation

A written opinion for the treating clinician on the family history, the choice of genetic test or the interpretation of a result, such as a variant of uncertain significance. Pseudonymised data wherever possible.

Support for oncologist-led testing

For units where clinicians order germline tests themselves: referral and testing criteria, information and consent documents, result-letter templates, and training for the team.

Periodic review of variants of uncertain significance

Option of an agreed periodic review of the unit’s variants of uncertain significance, under the terms of the collaboration.

Informing and testing relatives

Letters for relatives, organisation of their testing (cascade testing) and tracking of uptake, so the information reaches the people it concerns.

Teaching

Seminars and courses on genetic counselling and hereditary cancer for doctors, nurses and students.

What collaboration brings to your service

Integrating genetic counselling into the services of a clinic or hospital does not necessarily require a separate in-house department. Through a flexible collaboration, your team can access specialist support, structured referral processes, evidence-based interpretation of results and coordination of genetic care for patients and their families.

This can help your service expand the care it offers, make more effective use of clinicians’ time and strengthen continuity of care without the fixed cost of staffing a new service. The scope and scale of collaboration are tailored to each team’s needs and case volume.

Flexible collaboration

Contact me to discuss your team’s needs and receive a tailored proposal for working together.

Independence and data protection

I receive no fees or other benefits from laboratories or companies for referrals or for the choice of tests. When a collaboration requires access to patient data, processing is covered by a written data-processing agreement under the GDPR and, wherever possible, uses pseudonymised data.

Professional standard

The European Board of Medical Genetics (EBMG) sets the common standards for genetic counsellors in Europe: a master’s in genetic counselling from an accredited programme, supervised clinical experience in a multidisciplinary team, peer assessment and continuing education. My MSc at the Universitat Autònoma de Barcelona is accredited by the EBMG, and my clinical training took place in hereditary cancer services at the Catalan Institute of Oncology and in genetics at Germans Trias i Pujol University Hospital.

The European standard in detail

Experience

Research on genetic counselling in oncology

My research includes how genetic counselling is integrated into multidisciplinary oncology teams across Europe.

Teaching

My teaching experience includes genetic counselling, as well as courses in genetics, molecular and developmental biology in undergraduate and postgraduate programmes.

Scope

As a genetic counsellor, I do not diagnose or prescribe. I support patients’ understanding and decision-making, and return clinical decisions to the treating team.

Refer a patient or collaborate with your team

Get in touch about referrals, your service’s needs or a tailored collaboration proposal.

Form for professionals